Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
GJD4 Antisense RNA 1 (GJD4-AS1) is a long noncoding RNA gene annotated in humans as an antisense transcript overlapping with the GJD4 gene. The function, biological processes, molecular family, and any disease involvement of GJD4-AS1 are currently unknown, and there is no evidence it is recognized as a therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on GJD4 Antisense RNA 1 (GJD4-AS1).